Skip to main content

Table 1 Demographics and biomarkers levels

From: Clinical performance and head-to-head comparison of CSF p-tau235 with p-tau181, p-tau217 and p-tau231 in two memory clinic cohorts

 

Paris cohort (n = 212)

BIODEGMAR cohort (n =175 )

CU

Aβ−

MCI

Aβ−

Dementia Aβ−

MCI

Aβ+

Dementia

Aβ+

P-value

CU

Aβ−

MCI

Aβ−

Dementia

Aβ−

CU

Aβ+

MCI

Aβ+

Dementia Aβ+

P-value

n = 21

n = 47

n = 27

n = 40

n = 77

 

n=11

n=28

n=19

n=7

n=46

n=64

 

Age, years

64.6

(9.42)

66.30 (9.58)

66.04 (7.73)

72.40 (7.96)a

71.90 (8.61)a

< 0.0001

70.4

(5.8)

71.4

(6.1)

70.0

(6.1)

70.1

(4.5)

74.4

(4.8)

73.5

(4.5)

0.009

Male (% male)

8

(38%)

16

(34%)

15

(56%)

16

(40%)

30

(39%)

0.338

3

(27%)

16

(57%)

6

(32%)

2

(29%)

19

(41%)

25

(39%)

0.141

APOEε4 carriers

7/21

(33%)

5/47

(11%)a

7/26

(27%)

22/40

(55%)

51/76

(67%)a

< 0.001

1/10

(10%)

4/24

(17%)

3/18

(17%)

3/7

(43%)

24/38 (63%)a

39/62 (61%)a

< 0.02

Level of education, years

11.5 (2.4)

10.7 (2.2)

11.0 (2.1)

10.0 (2.5)

10.6 (2.4)

0.299

10.4 (4.9)

8.5 (4.6)

7.75 (4.7)

11.4 (4.0)

8.4 (4.6)

7.7 (3.6)

0.0267

MMSE score

27.14 (2.45)

24.00 (4.01)a

23.85 (4.87)a

23.82 (3.84)a

19.09 (5.74)a

< 0.0001

28.4

(2.3)

25.6

(2.7)

22.2

(5.8)a

28.7

(1.5)

23.3

(3.9)a

20.4

(4.8)a

< 0.0001

Core biomarkers Lumipulse

CSF Aβ1–42

1060.95

(245.23)

1090.66 (468.75)

1027.78 (354.02)

553.00 (209.36)a

497.88 (155.27)a

< 0.0001

1186

(357)

1164

(549)

986

(449)

634

(206)a

556

(178)a

522

(153)a

< 0.0001

CSF Aβ1–42/40

0.093

(0.010)

0.088 (0.012)

0.09

(0.01)

0.044 (0.009)a

0.042 (0.009)a

< 0.0001

0.091 (0.017)

0.0879 (0.012)

0.091 (0.017)

0.049 (0.008)a

0.043 (0.009)a

0.043 (0.008)a

< 0.0001

CSF pTau, pg/mL

32.25

(8.16)

40.97 (20.81)

33.59

(10.50)

94.80 (47.31)a

113.53 (60.02)a

< 0.0001

56.8

(31.4)

50.2

(30.9)

41.0

(24.4)

59.1

(14.3)

112

(59.6)a

121.4 (57.9)a

< 0.0001

CSF t-tau, pg/mL

236.62

(63.69)

333,085 (172.630)

362.26

(341.90)

594.83 (285.45)a

722.01 (393.87)a

< 0.0001

307

(141)

357

(230)

311

(166)

407

(107)

669

(323)a

759

(342)a

< 0.0001

Biomarker profile

Normal profile

21 (100%)

39 (83%)

25 (92%)

0 (0%)

0 (0%)

 

9 (82%%)

24 (86%)

17 (89%)

0 (0%)

0 (0%)

0 (0%)

 

AD continuum

0 (0%)

0 (0%)

0 (0%)

40 (100%)

77 (100%)

 

0 (0%)

0 (0%)

0 (0%)

7 (100%)

46 (100%)

64 (100%)

 

A+T−

/

/

/

7 (18%)

10 (13%)

 

/

/

/

6 (86%)

11

(24%)

3

(5%)

 

A+T+

/

/

/

33 (82%)

67 (87%)

 

/

/

/

1

(14%)

35

(76%)

61

(95%)

 

SNAP

0

(0%)

8 (17%)

2 (8%)

0

(0%)

0

(0%)

 

2 (18%)

4 (14%)

2 (11%)

0 (0%)

0 (0%)

0 (0%)

 

CSF p-tau biomarkers

CSF N-term p-tau181, pg/mL

224.72

(66.33)

300.708 (245.52)

242.23 (110.58)

965.91 (628.08) a

1223.94 (802.66)a

< 0.0001

427

(110)

410

(164)

426

(168)

494

(129)

771

(257)a

871

(343)a

< 0.0001

CSF N-term p-tau217, pg/mL

1.84

(0.94)

2.90

(2.50)

2.14

(1.67)

13.88 (9.48)a

16.62 (9.74)a

< 0.0001

N/A

N/A

N/A

N/A

N/A

N/A

N/A

CSF N-term p-tau231, pg/mL

271.93

(64.74)

325.05 (148.44)

286.62 (114.72)

657.64 (205.53)a

800.58 (640.95)a

< 0.0001

313

(211)

348

(201)

331

(236)

541

(144)

788

(399)a

893

(469)a

< 0.0001

CSF N-term p-tau235, pg/mL

11.19

(2.94)

12.74 (5.67)

11.56 (4.30)

24.75 (8.11)a

28.03 (11.52)a

< 0.0001

17.6

(8.10)

18.5

(11.3)

17.4

(7.23)

23.1

(3.65)

34.8

(12.9)a

41.6

(20.0)a

< 0.0001

  1. Data is shown as mean (SD) or n (%), as appropriate. We used Kruskal-Wallis test to compare age between groups and Pearson’s chi-square to compare sex and APOE ε4 frequencies between groups. Fluid biomarkers levels and MMSE were compared with a one-way ANOVA adjusted by age and sex. aP < 0.0001 versus controls. aP < 0.05 versus CU Aβ−
  2. 1-42 β-amyloid 42, 1-40 β-amyloid 40, CSF Cerebrospinal fluid, CU Cognitively unimpaired, MCI Mild cognitive impairment, MMSE Mini-Mental State Examination, N-term N-terminal, p-tau181 Tau phosphorylated at threonine 181, p-tau217 Tau phosphorylated at threonine 217, p-tau231 Tau phosphorylated at threonine 231, p-tau235 Tau phosphorylated at threonine 181, t-tau Total tau